MedTrace Logo

Escalation vs. Induction Therapy Strategy in Patients With Early-Onset MS After Age 50

NCT07313462 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 830

Last updated 2026-01-02

No results posted yet for this study

Summary

The objective of this study is to evaluate the risk of inflammatory disease activity by retrospectively comparing two therapeutic strategies (escalation group and induction group). The investigators also aim to identify factors associated with inflammatory relapse and treatment-related complications.

Conditions

  • Multiple Sclerosis (MS)

Sponsors & Collaborators

  • University Hospital, Strasbourg, France

    lead OTHER

Eligibility

Min Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-02-07
Primary Completion
2026-02-28
Completion
2026-02-28

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07313462 on ClinicalTrials.gov